Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G R GREENBERG

Showing results (141-150 of 147) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 147 results.
The New England Journal of Medicine|June 1, 2000
A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group InvestigatorsB G Feagan, R N Fedorak, E J Irvine, et al.
Alimentary Pharmacology & Therapeutics|April 3, 2014
A prospective cohort study to determine the relationship between serum infliximab concentration and efficacy in patients with luminal Crohn's diseaseB G Levesque, G R Greenberg, G Zou, et al.
American Journal of Human Genetics|April 25, 2000
Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility lociJ D Rioux, M S Silverberg, M J Daly, et al.
Gastroenterology|December 12, 1997
Risk and significance of endoscopic/radiological evidence of recurrent Crohn's diseaseR S McLeod, B G Wolff, A H Steinhart, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|March 21, 2008
Review and clinical perspectives for the use of infliximab in ulcerative colitisR Panaccione, R N Fedorak, G Aumais, et al.
Alimentary Pharmacology & Therapeutics|July 16, 2013
Review article: a clinician's guide for therapeutic drug monitoring of infliximab in inflammatory bowel diseaseR Khanna, B D Sattin, W Afif, et al.
Nature Genetics|October 5, 2001
Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn diseaseJ D Rioux, M J Daly, M S Silverberg, et al.
Pageof 15

Showing results (141-150 of 147) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 147 results.
The New England Journal of Medicine|June 1, 2000
A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group InvestigatorsB G Feagan, R N Fedorak, E J Irvine, et al.
Alimentary Pharmacology & Therapeutics|April 3, 2014
A prospective cohort study to determine the relationship between serum infliximab concentration and efficacy in patients with luminal Crohn's diseaseB G Levesque, G R Greenberg, G Zou, et al.
American Journal of Human Genetics|April 25, 2000
Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility lociJ D Rioux, M S Silverberg, M J Daly, et al.
Gastroenterology|December 12, 1997
Risk and significance of endoscopic/radiological evidence of recurrent Crohn's diseaseR S McLeod, B G Wolff, A H Steinhart, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|March 21, 2008
Review and clinical perspectives for the use of infliximab in ulcerative colitisR Panaccione, R N Fedorak, G Aumais, et al.
Alimentary Pharmacology & Therapeutics|July 16, 2013
Review article: a clinician's guide for therapeutic drug monitoring of infliximab in inflammatory bowel diseaseR Khanna, B D Sattin, W Afif, et al.
Nature Genetics|October 5, 2001
Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn diseaseJ D Rioux, M J Daly, M S Silverberg, et al.
Pageof 15